BamSEC and AlphaSense Join Forces
Learn More

Adverum Biotechnologies Inc.

NASDAQ: ADVM    
Share price (8/14/25): $2.77    
Market cap (8/14/25): $58.1 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.5
from 10-Q 23 pages Registration Rights Agreement
12/34/56
EX-10.4
from 10-Q 17 pages Pre-Funded Common Stock Purchase Warrant Adverum Biotechnologies, Inc
12/34/56
EX-10.3
from 10-Q 38 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 10-Q 10 pages Adverum Biotechnologies, Inc. 2014 Employee Stock Purchase Plan Amended and Restated on May 13, 2025
12/34/56
EX-10.1
from 8-K 25 pages Adverum Biotechnologies, Inc. 2024 Equity Incentive Award Plan (As Amended and Restated June 17, 2025) Article 1 Purpose
12/34/56
EX-10.18
from 10-K 7 pages Material contract
12/34/56
EX-10.4
from 10-Q 4 pages Adverum Biotechnologies, Inc. Non-Employee Director Compensation Policy Adopted by the Compensation Committee: May 22, 2024
12/34/56
EX-10.2
from 8-K 23 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 40 pages Securities Purchase Agreement
12/34/56
EX-10.6
from 10-Q 9 pages Adverum Biotechnologies, Inc. Change in Control and Severance Agreement
12/34/56
EX-10.5
from 10-Q 6 pages I Am Pleased to Offer You a Position With Adverum Biotechnologies, Inc. (The “Company”) as Chief Financial Officer, Reporting to the Chief Executive Officer, Laurent Fischer, M.D. You Will Work at Our Office Located in Redwood City, Ca. of Course, the Company May Change Your Position, Duties, and Work Location From Time to Time in Its Discretion. if You Decide to Join US, This Letter Agreement (The “Agreement”) Memorializes Your Compensation and Other Employment Terms. These Terms Will Become Effective on the Date You Join the Company (The “Hire Date”). 1. Compensation and Benefits. Base Compensation
12/34/56
EX-10.4
from 10-Q 12 pages Consulting Agreement
12/34/56
EX-10.3
from 10-Q 11 pages Separation Agreement and General Release of Claims
12/34/56
EX-10.3
from 10-Q 6 pages Third Amendment to Lease Agreement and First Amendment to Consent to Sublease
12/34/56
EX-10.20
from 10-K 5 pages Confidential Consulting Agreement
12/34/56
EX-10.4E
from 10-K 5 pages Fourth Amendment to Lease
12/34/56
EX-10.4D
from 10-K 5 pages Third Amendment to Lease
12/34/56
EX-10.4
from 10-Q 10 pages Adverum Biotechnologies, Inc. 2014 Employee Stock Purchase Plan Amended and Restated on June 10, 2022
12/34/56
EX-10.3
from 10-Q 7 pages Consulting Agreement
12/34/56
EX-10.2
from 10-Q 10 pages Separation Agreement and General Release of Claims
12/34/56